Ethnopharmacological relevance: Bacterial infections remain a significant threat to human health. Due to the emergence of widespread antibiotic resistance, development of novel antibiotics is required in order to ensure that effective treatment remains available. There are several reports on the ethnomedical use of Tabernaemontana elegans pertaining to antibacterial activity.
Introduction
A crisis of antibiotic resistance is looming globally. Resistance mechanisms have been identified for all classes of antibiotics available (Gold and Moellering, 1996) and in certain bacterial strains, multiple resistance mechanisms have been acquired (Hawkey and Jones, 2009) . Infections caused by such strains are difficult and more costly to treat, and are associated with higher incidences of mortality and morbidity, clearly demonstrating the clinical impact of antibiotic resistance (Sefton, 2002) . (World Health Organisation, 2010b) . The treatment of MDR-TB requires the use of second-line anti-tuberculosis agents, which are 10 times more expensive due to the longer duration of treatment required (Dorman and Chaisson, 2007) , and is associated with greater toxicity (Johnson et al., 2006) .The implications of the multi/extensively drug-resistant tuberculosis (M/XDR-TB) for public health are not fully known, but as the treatment of TB intensifies globally, the proportion of M. tuberculosis strains that are drug-resistant is bound to rise. This is especially true in high-burden, low-resource settings, where the majority of M/XDR-TB cases are found.
It has been over 60 years since the first strains of methicillin-resistant
Staphylococcus aureus (MRSA) were identified. Previously, the strains of MRSA were overwhelmingly associated with nosocomial settings (Salgado et al., 2003) , however, the rapid evolution of MRSA has garnered it the ability to cause community-acquired infections in previously-healthy young adults and children. In case studies of patients with invasive (i.e. non skin and soft-tissue) communityacquired MRSA infections, mortality rates have been found to be as high as 35% (Hageman et al., 2006) . Vancomycin remains the agent of choice in serious MRSA infections (Gemmel et al., 2006) . This reliance on vancomycin for the treatment of serious MRSA infections is not a sustainable situation, as vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus (VISA and VRSA, respectively) strains have been reported in the literature (Nannini et al., 2010) . These infections, without the development of new antibiotics, will represent a growing source of mortality in the years to come.
Tabernaemontana elgans (Stapf.) (syn. Conopharyngia elegans (Stapf.)), a member of the Apocynaceae family, is a small tree found in evergreen river fringes at low altitudes and in coastal scrub forest (Coats Palgrave et al., 2003) . It is known in English as the toad tree due to the brown, wart-like skin of its fruit. There are several reports of the ethnomedical use of T. elegans pertaining to antibacterial activity: a root decoction is applied as a wash to wounds, and drunk for pulmonary diseases and chest pains by the VhaVenda (Arnold and Gulumian, 1984) and Zulu (Watt and Breyer-Brandwijk, 1962 ) people of South Africa. Other ethnomedical usages include treatment of heart diseases with the seeds, stem-bark and roots, the root-bark and fruits for cancer treatment, and a root decoction is said to have aphrodisiac properties (Neuwinger, 1966) .
T. elegans has previously been identified as having antibacterial activity against S. aureus and antimycobacterial activity against M. smegmatis (Pallant and Steenkamp, 2008) , as well as anti-fungal activity against Candida albicans (Steenkamp et al., 2007) . An earlier study identified T. elegans as one of eight Tabernaemontana species possessing antibacterial activity against Gram-positive bacteria (Van Beek et al., 1984) . In these studies, the compound(s) responsible for the reported biological activity was not identified.
Previous phytochemical research has shown T. elegans to be particularly rich in monoterpenoidindole alkaloids (Gabetta et al., 1975; Bombardelli et al., 1976; Danieli et al., 1980; Van der Heijden et al., 1986) . These alkaloids, which are structurally diverse, are commonly found in many members of the genus and are considered chemotaxonomically important (Zhu et al., 1990 ). To date, over 300 of these alkaloids have been isolated (Cardoso et al., 1998) .
The biological activity of T. elegans, especially in terms of antibacterial activity, which has thus far been reported for crude extracts, remains less thoroughly investigated.
Due to the clear need for new agents which may be used for the treatment of tuberculosis and other bacterial infections, this study was aimed at isolating the active fraction responsible for the antibacterial activity of this plant.
Materials and methods

Plant material and extraction procedures
Roots of Tabernaemontana elegans (Stapf.) were collected from the Venda region of Limpopo, South Africa. The plant material was authenticated and a voucher specimen (NH 1920) deposited at the Soutpanbergensis Herbarium (Makhado, Limpopo). Powdered root was extracted by maceration in ethanol at a ratio of 100 g plant material to 1 l solvent. The flask was placed in an ultrasonic bath for 1 h, then left to stand overnight at ambient temperature. The extract was centrifuged (1000g, 5 min) and vacuum-filtered through 0.44 μm filters. The plant material was macerated twice under similar conditions and the three extracts combined.
Crude extract
The ethanol maceration was concentrated to dryness with a rotary evaporator at 40˚C under reduced pressure. Liquid-liquid extraction (LLE) was performed using distilled water and hexane. The aqueous fraction was lyophilized and stored at 4˚C in a desiccator until use.
Alkaloidal fraction
An alkaloidal fraction (AF) was obtained by an acid-base extraction method. An aliquot of the ethanol maceration was partitioned between 2% acetic acid and hexane, with the hexane fraction being discarded. The aqueous layer was adjusted to pH 10 with ammonia in order to precipitate the alkaloids present. Using LLE, the precipitated alkaloids were collected into chloroform and dried using sodium sulphate, (1.2% dry weight/weight). The AF was dried at 40˚C and reconstituted in ethanol to a concentration of 100 mg/ml and stored at -20˚C until use.
Chemical characterisation
Phytochemical screening of the crude extract
Compounds in the crude extract were separated on silica TLC plates (10 x 10 cm) using a mobile phase of 17:2:1 ethyl acetate:2-propanol:ammonia. Developed TLC plates were assessed for the presence of various phytochemical groups, by utilization of visible and ultraviolet (UV) light, in addition to various spray reagents (Stahl, 1969; Harborne, 1998) which were selected to visualise specific classes of compounds (alkaloids, coumarins, essential oils, flavonoids, phenols and sterols/steroids).
Gas chromatography mass spectrometry (GC-MS) analysis of the alkaloidal fraction
GC-MS analysis of the crude extract and alkaloidal fraction was performed using an Agilent 7890 GC-MS equipped with a DB5-MS column (30m x 0.32 μm i.d., film thickness 0.25 mm, J&W Scientific). Helium was used as the carrier gas at a constant flow, and the injection split ratio was 50:1. The injector temperature was 280°C. Column temperature was programmed to rise from 80°C to 310°C at 10°C/min for 23 min, then maintained at 310°C for 7 min (Total run time 30 min).
The acquisition mode selected for mass spectrometry was scan mode, with a scan range of 35 -550 Da and a threshold of 100 counts per second (cps). Solvent delay was 4 min. Quadrupole temperature was 150°C, with the transfer line temperature set to 280°C. GC and mass spectrometry parameters, data collection and analysis were performed by Agilent Chemstation. Identity of the compounds was determined using the National Institute of Standards and Technology (NIST) library.
Anti-microbial assays
Micro-organisms
The crude extract and alkaloidal fraction were tested for antibacterial activity against 
Bacterial inocula
Bacterial inocula for all micro-organisms apart from M. tuberculosis were prepared by transferring colonies from 24 h, freshly prepared subcultures (72 h McFarland turbidity standard. An inoculum (100µl) was added to a BACTEC vial, incubated at 37˚C, with Growth Index (GI) readings taken daily. Once the GI reached 400 -500, contamination of the inoculum was assessed by overnight growth on blood agar. If free of contamination, the inocula were used on the BACTEC assay described below.
Broth micro-dilution assay
Determination of the minimum inhibitory concentration (MIC) for the all the bacterial species, apart from the strains of M. tuberculosis, was performed using the broth micro-dilution assay (National Committee for Clinical Laboratory Standards, 2008).
Stock solutions of the test samples and antibiotic standards were prepared in distilled water. The concentrations of the stock solutions were 4.096 mg/ml for the crude extract, 2.048 mg/ml for the alkaloidal and basic fraction, 32 µg/ml for ampicillin and 2 µg/ml for ciprofloxacin. In order to increase the solubility of the alkaloidal fraction in distilled water, the stock solution was acidified to ≈ pH 6.5 with acetic acid. All stock solutions were kept at -20˚C until use.
Ampicillin and ciprofloxacin were serially diluted in the media and served as the positive control for the Gram-positive bacteria and Gram-negative bacteria and M.
smegmatis, respectively. Wells containing 50 µl of media without plant extracts or antibiotics were used as growth controls. Wells containing 100 μl of medium served as the sterility control. Inocula (50 µl) was added to the all wells except the sterility controls to give a final volume of 100 µl before incubating at 37˚C in an ambient atmosphere for 24 h (72 h in the case of M. smegmatis). The MIC was defined as the lowest concentration of the sample that was able to visibly inhibit the growth of the bacteria.
From all wells that demonstrated no apparent bacterial growth, the entire well contents (100 µl) were streaked in a straight line on a Mueller Hinton agar plate.
After allowing the broth to dry, which prevented antibiotic carry-over, the plate was streaked to form a lawn of bacterial growth and incubated for 24 h at 37˚C (72 h in the case of M. smegmatis). A 100-fold dilution of the starting inoculum was used to determine the starting colony count (Anhalt et al., 1980) . The minimum bactericidal concentration (MBC) was defined as the concentration of a compound or extract that resulted in >99.9% killing of bacterium relative to the concentration of the bacterium present in the inoculum (National Committee for Clinical Laboratory Standards, 2008). Each assay was performed in triplicate and on at least three different occasions.
BACTEC radiometric assay
The BACTEC radiometric broth dilution assay was used to determine the MIC of the samples for the two strains of M. tuberculosis (Siddiqi et al., 1981) . Starting concentrations were 1.052 mg/ml, 512 μg/ml and 0.1 μg/ml for the crude extract, alkaloidal fraction and isoniazid, respectively. Three vials were used as controls, two containing only medium and the vehicle, representing solvent controls, while the third contained only medium and was the growth control. From the BACTEC vial containing the inoculum of M. tuberculosis, 100 µl was transferred to the vials containing the samples and the two solvent control vials. In the growth control vial, a 1:100 dilution of the inoculum was added, representing 1 x 10 3 -1 x 10 2 CFU/ml, or 1% of the initial mycobacterial population.
Inoculated vials were incubated at 37˚C, with each vial assayed at 24 h intervals until the growth control vial reached a GI of greater than 30. The following day, final readings were taken and the ΔGI determined for all samples. The MIC was defined as the lowest concentration of a sample for which the ΔGI was less than the ΔGI of the growth control. If the GI of the sample was greater than 100, M. tuberculosis was deemed to be resistant to the sample, even if the ΔGI was less than that of the growth control.
Synergistic antimicrobial activity assays
Assessment of the synergistic activity between the alkaloidal fraction and the antibiotics utilized as controls for the broth micro-dilution assay was performed using a chequerboard synergy testing protocol (Bonapace et al., 2000) . This was performed for all susceptible bacterial strains, however, the methodology was adapted for used in the BACTEC assay for M. tuberculosis.
A dilution series of the alkaloidal fraction and of the antibiotics was made up in
Mueller Hinton broth, with the concentration range representing 1/8 x MIC -1 x MIC for the sample against the specific bacteria, as previously determined in the broth micro-dilution assay.
In a four-by-four grid on a 96 well microtitre plate, 25 μl of the dilution series of the alkaloidal fraction was added along the x-axis of the grid, while 25 μl of the antibiotic dilution series was added to the y-axis of the grid. Wells containing 50 μl of samplefree medium served as growth controls and wells containing 100 μl of medium served as sterility controls. Each well containing 50 μl of the alkaloidal fraction/antibiotic mixture was inoculated with 50 μl of the bacterial inocula. The microtitre plates were incubated at 37˚C in an ambient atmosphere for 24 h (72 h in the case of M. smegmatis).
For M. tuberculosis, BACTEC vials were arranged in a four-by-four grid, and 50 μl of the alkaloidal fraction was added along the x-axis of the grid, while 50 μl of the antibiotic dilution series was added to the y-axis of the grid. The rest of the BACTEC assay was performed as described above.
The mean fractional inhibitory concentration (FIC) was used to interpret the results of the chequerboard synergy assay. The FIC was defined as:
The FIC was calculated for each sample indicating no growth along the growth/inhibition interface of the grid. Synergism between the samples was defined as a mean FIC of ≤ 0.5, additivity as a value of > 0.5 -4 and antagonism as a value least three different occasions.
Cytotoxicity assays
Stock solutions of the test reagents were prepared by re-constitution in distilled water. The concentrations of the stock solutions were 410 μg/ml for the crude extract and the basic aqueous fraction, 205 μg/ml for the alkaloidal fraction, and 1% (w/v) for saponin. In order to increase the solubility of the alkaloidal fraction in distilled water, the stock solution was acidified to pH 6.5 with acetic acid. All stock solutions were kept at -20˚C until use.
Cell lines
Cytotoxicity of the crude ethanol extract and alkaloidal fraction was determined against normal human dermal fibroblasts (Southern Medical, SA), human lymphocytes, HepG2 hepatocytes (ATCC HB 8065) and THP1 macrophages (ATCC TIB 2.2).
Human lymphocytes were isolated from whole blood (Anderson et al., 1993) obtained after ethical approval (University of Pretoria) from healthy volunteers. The media and cell concentrations used in the assays were DMEM-F12 and 5 x 10 4 cells/ml, RMPI-1640 and 2 x 10 6 cells/ml, EMEM and 5 x 10 5 cells/ml, THP-medium and 1 x 10 5 cells/ml for the normal human dermal fibroblasts, human lymphocytes, HepG2 and THP-1 cells, respectively. All media was supplemented with 10% foetal calf serum. To each well of a microtitre plate, 100 μl of the cell suspension was added. For the fibroblasts and hepatocytes, an additional 80 μl of FCSsupplemented medium was added to the microtitre plates which were incubated for 24 h at 37°C in a humidified atmosphere of 5% CO 2 to allow for cellular adhesion.
Lymphocytes ( 
Cytotoxicity assays
Two-fold serial dilutions of the crude extract (1.6 -204.8 μg/ml), alkaloidal fraction (0.1 -12.8 μg/ml) and aqueous fraction (3.2 -410 μg/ml) were prepared. Saponin the cytotoxicity assays were conducted. The MTT assay was performed as described by Mosmann (1983) , and the Neutral Red uptake assay as described by Borenfreund and Puerner (1986) . All assays were conducted in triplicate, on three different days.
The concentration of sample that prevented the survival of 50% of the cell population (IC 50 ) was determined by non-linear regression from optical density measurements.
Sample optical density values were converted to a percentage of the average growth of control wells. Non-linear regression, using a sigmoidal dose-response curve model with a bottom constraint of 0, was performed using GraphPad Prism 4.0 software.
Results and discussion
Phytochemical screening of the crude extract indicated the presence of: alkaloids, amines, essentials oils, phenols and steroids/sterols. Phytochemical screening of other Tabernaemontana species support these findings. The presence of triterpenes/triterpenoids and steroids (Cardoso et al., 1998) , flavonoids, plenylpropanoids and phenolic acids (Chattipakorn et al., 2007) and phytosterols (Mederios et al., 2001 ) has been reported.
GC-MS analysis of the crude extract and alkaloidal fraction indicated the presence of two major compounds that together accounted for more than 75% of all the detected compounds. These compounds, identified with a greater than 90% certainty by comparison to the NIST database, were the indole alkaloids, dregamine [20α, 19,20- dihydro-3-oxoVobasan-17-oic acid methyl ester] and voacangine (12-methoxyibogamine-18-carboxylic acid methyl ester) (Fig. 1) . Dregamine has been
reported to be present in other species of Tabernaemontana, and has previously been isolated from T. elegans (Gabetta et al., 1975; Van der Heijden et al., 1986) .
The presence of voacangine in various Tabernaemontana species is also known (Kingston, 1978) . The alkaloidal fraction demonstrated antibacterial activity against the same organisms as that of the crude extract, but at a significantly lower concentration (Table 1) . These results support the hypothesis that the alkaloids enriched in the alkaloid subfraction, are primarily responsible for the antimicrobial activity of T.
elegans.The presence of drug resistance in the bacteria from clinical isolates tested in this study did not have an effect on the susceptibility of the bacteria to the crude extract or the alkaloidal fraction. This effect has been reported for another species of Tabernaemontana (Ruttoh et al., 2009 ).
The alkaloidal fraction of T. catharinensis has known activity against 3 species of mycobacteria, as well as Gram-positive and Gram-negative bacteria (Pereira et al., 2005) . Isolated alkaloids from various Tabernaemontana species: conoduramine, conodurine, and voacamine, possess strong antibacterial activity against Grampositive bacteria (Van Beek et al., 1984; 1985) . The alkaloids ibogamine and voacangine have proven antimycobacterial activity (Rastogi et al., 1998) . None of these compounds, however, have been previously identified in T. elegans, suggesting that the pharmacophore responsible for the antibacterial activity may be common to a number of alkaloids in this genus.
All MBC values of the crude extract and alkaloidal fraction were within two serial elegans on cell viability for the cell lines and primary cultures are presented in Table   2 . The IC 50 values for the crude ethanolic extract in both assays ranged from 1.93 μg/ml -19.27 μg/ml and showed dose-dependent response curves. Smaller IC 50 values were obtained for the alkaloidal fraction, ranging from 1.11 μg/ml -9.81 μg/ml.
The lower IC 50 values obtained for the alkaloidal fraction, combined with the nontoxicity of the basic fraction, demonstrate that it is primarily the indole alkaloids of T.
elegans that are responsible for the cytotoxicity observed in the crude extract.
Previous research on crude extracts of Tabernaemontana species has shown conflicting evidence of cytotoxicity. An aqueous extract of T. elegans demonstrated weak toxicity to human lymphocytes, with IC 50 concentrations ranging between 90 -160 μg/ml (Pallant and Steenkamp, 2008) . The earliest investigation of the cytotoxic effects of Tabernaemontana species showed that an aqueous methanolic extract of T. arborea possessed an IC 50 of 8 μg/ml against P-388 cells (murine lymphocytic leukaemia) (Kingston et al., 1978) . Methanolic and dichloromethane root extracts of T. divaricata were were found to be cytotoxic in COR L23 (human non-small cell lung cancer) and MCF7 (human breast adenocarinoma) cell lines, however, the aqueous extract did not produce an effect even at the highest concentration tested (> 25 μg/ml) (Lee and Houghton, 2005) . Another study on T. divaricata confirmed these results (Thind et al., 2008) . On the contrary, a methanol extract of T. divaricata had no effect on resting human mesangial cells (Kuo et al., 1999 ). An ethyl acetate extract of the stem bark of T. laeta, and leaf extracts of T. amydalifolia exhibited no cytotoxicity (IC 50 > 20 μg/ml) in a KB human oral epidermoid carcinoma cell line (You et al, 1994; Ankli et al., 2002) . A methanol extract of the leaves of T.obliqua was reported to have cytotoxic effects against promonocytic U937 cells, however, the IC 50 value (231.6 μg/ml ± 2.7 μg/ml) provided is substantially higher than what is deemed to be physiologically significant (Weniger et al., 2001 ).
Several possible explanations exist for the lack of cytotoxicity activity reported in some of the crude extracts. It may be related to factors influencing the concentration of the alkaloids in the plant, such as pre-cursor availability (Dagnino et al., 1995; Lucumi et al., 2001) , microbial attack (Fulton et al., 1994) , or other environmental stressors, and factors influencing the concentration of alkaloids in the crude extract, such as plant part as well as the method of extraction and solvent system selected for extraction (Pereira et al., 2004) .
From the literature, more than 40 isolated Tabernaemontana alkaloids have been assayed for cytotoxicity (Pallant, 2010) . The majority of these alkaloids have IC 50 values below 20 μg/ml, indicating significant cytotoxic effects regardless of the type of cell or the cytotoxicity assay employed. Regarding the two alkaloids identified in this study, cytotoxicity has been reported for voacangine (Kingston, 1978;  cytotoxic indole alkaloids from Tabernaemontana Tables   Table 1. MIC and MBC values obtained in the broth micro-dilution assay. 
